Madrigal Pharmaceuticals, Inc. (MDGL) compared with its closest peers (IONS, ACAD, PBH, ARWR, LKFT). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Ionis Pharmaceuticals, ACADIA Pharmaceuticals, Prestige Consumer Healthcare, Arrowhead Pharmaceuticals, Lakefront Biotherapeutics, Collegium Pharmaceutical, Corcept Therapeutics, Emergent BioSolutions, Indivior Pharmaceuticals and Pacira BioSciences share Madrigal Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Ionis Pharmaceuticals, Inc. (IONS) | $9.93B | -33.2 |
| ACADIA Pharmaceuticals Inc. (ACAD) | $5.05B | 13.4 |
| Prestige Consumer Healthcare Inc. (PBH) | $2.43B | 14.1 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $12.31B | -3453.0 |
| Lakefront Biotherapeutics NV (LKFT) | $1.93B | 6.0 |
| Collegium Pharmaceutical, Inc. (COLL) | $882.75M | 19.4 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Indivior Pharmaceuticals Inc (INDV) | $4.35B | 12.7 |
| Pacira BioSciences, Inc. (PCRX) | $982.99M | 67.2 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
MDGL overview · MDGL earnings · MDGL financials · MDGL KPIs · MDGL documents · MDGL ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.